Keyphrases
Antiprogesterone
100%
Breast Cancer Prevention
100%
Transdermal
100%
Breast Cancer Patients
66%
Breast Cancer Cells
66%
Growth Rate
66%
Drug Class
33%
Active Substances
33%
Breast Cancer Treatment
33%
Newly Diagnosed
33%
Early Breast Cancer
33%
Daily Dose
33%
First-ever
33%
Progesterone Receptor
33%
Clinical Trials
33%
Rate-based Model
33%
Surgical Therapy
33%
Cells in Culture
33%
Progesterone
33%
Breast
33%
Placebo
33%
Medicine and Dentistry
Breast Cancer Prevention
100%
Transdermal
100%
Clinical Study
100%
Antigestagen
100%
Breast Cancer
100%
Cancer Cell
50%
Clinical Trial
25%
Placebo
25%
Drug Therapy
25%
Cancer Therapy
25%
Surgery
25%
Progesterone
25%
Progesterone Receptor
25%
Pharmacology, Toxicology and Pharmaceutical Science
Preclinical Study
100%
Clinical Study
100%
Transdermal
100%
Antigestagen
100%
Breast Cancer
100%
Clinical Trial
14%
Placebo
14%
Progesterone Receptor
14%
Progesterone
14%